SCHEMBL14720677

SCHEMBL14720677

O=C(Cc1ccc(C=C2CCN(C3CCC3)CC2)cc1)NC1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
POLB P06746 2/20 0.49
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
EPHX2 P34913 2/20 0.48
LMNA P02545 2/20 0.47
SIGMAR1 Q99720 2/20 0.45
ACKR3 P25106 1/20 0.42
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
GRIA2 P42262 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720817 0.87 SRD5A2 (0.43) SRD5A2NPC1RAB9APOLBALDH1A1
SCHEMBL14720988 0.83 SRD5A2 (0.49) SRD5A2NPC1RAB9APOLBALDH1A1
SCHEMBL14721400 0.83 SRD5A2 (0.48) SRD5A2POLBALDH1A1KMT2AKDM4E
SCHEMBL14731083 0.82 SRD5A2 (0.46) SRD5A2NPC1RAB9APOLBALDH1A1
SCHEMBL14720873 0.81 ALDH1A1 (0.54) SRD5A2NPC1ALDH1A1KMT2AKDM4E
SCHEMBL14720838 0.79 SRD5A2 (0.44) SRD5A2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL14721067 0.79 SRD5A2 (0.42) SRD5A2ALDH1A1KDM4ECYP2D6L3MBTL1
SCHEMBL14731157 0.78 SRD5A2 (0.37) SRD5A2ALDH1A1KMT2AEPHX2LMNA
SCHEMBL14720886 0.78 ALDH1A1 (0.50) SRD5A2ALDH1A1MEN1KMT2ALMNA
SCHEMBL14720430 0.76 SRD5A2 (0.43) SRD5A2POLBALDH1A1KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed